24/7 Advanced Online Pharmacology Updates
Earn 1- 9 Pharmacology CE in a Fun and Easy way!




What Makes Our Pharmacology "Simply the Best!"

    • Available 24/7 to use at your leisure
    • Features a concise, up-to-date lecture, full slideshow
    • PowerPoint slide handouts available for FREE download
    • Pharmacology courses specific to your specialty
    • Fast forward/rewind capability so you can be sure to master the material

    • No time limit
    • Smart phone and iPad compatible
    • Easy to obtain contact hours of pharmacology credit
      • Each video is accompanied by a 5-item quiz.
      • To obtain CE credit, one must score > 70%.
      • Each quiz may be repeated a maximum of 3 times.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15436, for the specified number of contact hours.
Barkley & Associates, Inc. is accredited by the American Association of Nurse Practitioners as an approved provider of
nurse practitioner continuing education. Provider number: 080518.

All NP state regulatory agencies (i.e., State Boards of Nursing) and national certifying bodies (e.g., ANCC, AANP, AACN, PNCB, and NCC) recognize and accept AANP CE credit for recertification! For initial prescriptive authority/furnishing, approval is pending in CA.




Click here for sample handouts 

In this comprehensive two-part series, nurse practitioners and clinical nurse specialists are updated on the latest information about cardiovascular pharmacotherapeutic agents as well as their side effects.

Included in this talk is information on:

Cardiovascvular Pharmacology Part 1

  • Hyperlipidemia, Lipoproteins, and the Pathogenesis of Plaque Rupture
  • Newest Lipid Lowering Guidelines
  • Treating Hyperlipidemia: HMG-CoA Reductase Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitor, Niacin, Other Agents for Dyslipidemia
  • Myocardial Infarction
  • Managing Hypertension: JNC-8 Guidelines (vs. JNC-7)
  • Pharmacologic Hypertension Agents: Diuretics, ACE-inhibitors, Angiotensin II Receptor Blockers, Calcium Channel Blockers, Beta-Blocking Agents, Peripheral Alpha1-Antagonists, Central Alpha2-Agonists, Arterial Vasodilators, Direct Renin Inhibitors, and Adrenergic Antagonists
  • Isolated Systolic Hypertension
  • Special Patient Populations
  • Hypertensive Crises vs. Emergencies

Cardiovascvular Pharmacology Part 2

  • Heart Failure: Key Concepts, Compensatory Mechanisms, and the Neurohormonal Model
  • Treating Heart Failure: Diuretics, ACE-Inhibitors, Angiotensin II-Receptor Blockers, Beta-blocking Agents, Aldosterone Antagonists, Vasodilators (HYD/Nitrate), Cardiac Glycosides, Digoxin, Dihydropyridine CCB, Inotropic Agents, Dobutamine, Milrinone, Intravenous Vasodilators, Nitroglycerin, Nitroprusside, Nesiritide, Mechanical Circulatory Support
  • Treating Anginal Syndromes: Nitrates, Beta-blockers, CCBs, and Ranolazine, Adjunct Pharmacologic Therapy
  • Drugs for Dysrhythmias
  • Drugs for Coagulation Problems: Anticoagulants, Antiplatelets, and Thrombolytic Agents
  • Treating Peripheral Arterial Disease
  • Hemostatic Agents